Detection of SARS-CoV-2 Delta Variant (B.1.617.2) in Domestic Dogs and Zoo Tigers in England and Jersey during 2021
Project: EVA-GLOBAL
Updated at: 01-12-2024
Resources
10.000+ items found
Alphavirus nsP3 organizes into tubular scaffolds essential for infection and the cytoplasmic granule architecture
Project: EVA-GLOBAL
Updated at: 01-12-2024
Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters
Project: EVA-GLOBAL
Updated at: 01-12-2024
<scp>Valosin‐containing protein ATPase activity regulates the morphogenesis of Zika virus replication organelles and v...
Project: EVA-GLOBAL
Updated at: 01-12-2024
Zika virus replication is impaired by a selective agonist of the TRPML2 ion channel
Project: EVA-GLOBAL
Updated at: 01-12-2024
The first detection of SARS-CoV-2 RNA in the wastewater of Bucharest, Romania
Project: EVA-GLOBAL
Updated at: 01-12-2024
Influence of a chronic Schistosoma mansoni infection on the outcomes of a SARS-CoV-2 infection in the hamster model
Project: EVA-GLOBAL
Updated at: 01-12-2024
New benefit-sharing principles for digital sequence information
Project: EVA-GLOBAL
Updated at: 01-12-2024
<i>In vivo</i> rescue of arboviruses directly from subgenomic DNA fragments
Project: EVA-GLOBAL
Updated at: 01-12-2024
JN.1 neutralizing antibody titers after XBB.1.5 monovalent vaccine boost in healthcare workers and people with HIV
Project: EVA-GLOBAL
Updated at: 01-12-2024
Fetal Zika virus inoculation in macaques revealed control of the fetal viral load during pregnancy
Project: EVA-GLOBAL
Updated at: 01-12-2024
First report of Tradescantia mild mosaic virus infecting Tradescantia × andersoniana in Germany
Project: EVA-GLOBAL
Updated at: 01-12-2024
Resistance to SARS-CoV-2 infection in camelid nasal organoids is associated with lack of ACE2 expression
Project: EVA-GLOBAL
Updated at: 01-12-2024
Sequestration of membrane cholesterol by cholesterol-binding proteins inhibits SARS-CoV-2 entry into Vero E6 cells
Project: EVA-GLOBAL
Updated at: 01-12-2024
In vitro activity of therapeutic antibodies against SARS-CoV-2 Omicron BA.1, BA.2 and BA.5
Project: EVA-GLOBAL
Updated at: 01-12-2024
Clinical efficacy of <i>SARS‐CoV‐2 Omicron</i>‐neutralizing antibodies in immunoglobulin preparations for the trea...
Project: EVA-GLOBAL
Updated at: 01-12-2024
Identification of FasL as a crucial host factor driving COVID-19 pathology and lethality
Project: EVA-GLOBAL
Updated at: 01-12-2024
An alternative method for SARS-CoV-2 detection with use modified fluorescent in situ hybridization
Project: EVA-GLOBAL
Updated at: 01-12-2024
A Gaussia luciferase reporter assay for the evaluation of coronavirus Nsp5/3CLpro activity
Project: EVA-GLOBAL
Updated at: 01-12-2024
Long-term trial of protection provided by adenovirus-vectored vaccine expressing the PPRV H protein
Project: EVA-GLOBAL
Updated at: 01-12-2024
Targeting sgRNA N secondary structure as a way of inhibiting SARS-CoV-2 replication
Project: EVA-GLOBAL
Updated at: 01-12-2024
An intranasal live-attenuated SARS-CoV-2 vaccine limits virus transmission
Project: EVA-GLOBAL
Updated at: 01-12-2024